Hmm. Good sleuthing guys. Be nice to get a definitive answer. Maybe have to ask DW or wait for sales/ commentary. At the very least it seems it will be a tailwind for MTX and the reputational hit to Integra should also be good for Novosorb. Why risk a biologic when there is a better, cheaper alternative?
As we’re already undervalued I’ve bought more anyway. Any uplift (and it’s only a question of how much) is a bonus.
Hmm. Good sleuthing guys. Be nice to get a definitive answer....
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.43 |
Change
0.110(4.74%) |
Mkt cap ! $1.677B | |||
| Open | High | Low | Value | Volume |
| $2.39 | $2.45 | $2.38 | $2.896M | 1.198M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | $2.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.43 | 9997 | 4 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |